Victory Capital Management
TFFP

Victory Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Victory Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-158
Closed -$16K – 3375
2020
Q1 		$16K Buy
+158
New +$18.8K ﹤0.01% 3181

Other funds holding TFFP

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PM
Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Victory Capital Management's TFFP Position: Q2 2020 in Review

Victory Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2020, closing a stake of 158 shares — an estimated $16K sold.

Victory Capital Management first reported a position in TFFP in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 14 funds tracked by Wall St. Rank hold TFFP as of Q2 2020.

  • Victory Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 158 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $16K.
  • Victory Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $16K in Q1 2020.
  • 14 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.